BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 30527357)

  • 1. Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
    Wu S; Wu D; Pan Y; Liu H; Shao Z; Wang M
    Pathol Res Pract; 2019 Feb; 215(2):292-301. PubMed ID: 30527357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
    Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
    Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
    Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
    Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
    Zhou L; Liu S; Li X; Yin M; Li S; Long H
    Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
    Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
    Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long intergenic non-coding RNA 00152 promotes lung adenocarcinoma proliferation via interacting with EZH2 and repressing IL24 expression.
    Chen QN; Chen X; Chen ZY; Nie FQ; Wei CC; Ma HW; Wan L; Yan S; Ren SN; Wang ZX
    Mol Cancer; 2017 Jan; 16(1):17. PubMed ID: 28109288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Positive Correlation Between the EZH2 and PD-L1 Expression in Resected Lung Adenocarcinomas.
    Toyokawa G; Takada K; Tagawa T; Hamamoto R; Yamada Y; Shimokawa M; Oda Y; Maehara Y
    Ann Thorac Surg; 2019 Feb; 107(2):393-400. PubMed ID: 30343006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bioinformatics analysis of RIOX2 gene in lung adenocarcinoma and squamous cell carcinoma.
    Sun B; Zhao H
    PLoS One; 2021; 16(12):e0259447. PubMed ID: 34855761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-platform analysis of methylation-regulated genes in human lung adenocarcinoma.
    Wang J; Yu XF; OUYang N; Luo QL; Zhao SY; Guan XF; Chen T; Li JX
    J Toxicol Environ Health A; 2019; 82(1):37-45. PubMed ID: 30626254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
    PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased miR-124 contributes to the epithelial-mesenchymal transition phenotype formation of lung adenocarcinoma cells via targeting enhancer of zeste homolog 2.
    Wu J; Li L; Zhang Y; Zhu J
    Pathol Res Pract; 2020 Jun; 216(6):152976. PubMed ID: 32370988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spindle assembly checkpoint complex-related genes TTK and MAD2L1 are over-expressed in lung adenocarcinoma: a big data and bioinformatics analysis].
    Liu Z; Guo Z; Long L; Zhang Y; Lu Y; Wu D; Dong Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Oct; 40(10):1422-1431. PubMed ID: 33118511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer.
    Yang L; He Y; Zhang Z; Wang W
    Biomed Res Int; 2020; 2020():4139320. PubMed ID: 32337246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas.
    Luo J; Ma K; Shi Y; Chen Z; Zhao M; Huang Y; Wang S; Xi J; Zhan C; Xu S; Wang Q
    Thorac Cancer; 2018 Dec; 9(12):1656-1663. PubMed ID: 30276966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation-based diagnostic and prognostic biomarkers of nonsmoking lung adenocarcinoma patients.
    Zhang X; Gao C; Liu L; Zhou C; Liu C; Li J; Zhuang J; Sun C
    J Cell Biochem; 2019 Aug; 120(8):13520-13530. PubMed ID: 30920015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of DNA Methylation and Gene Expression Datasets Identified MMP9 and TWIST1 as Important Pathogenic Genes of Lung Adenocarcinoma.
    Tian W; Li YS; Zhang JH; Li JJ; Gao JH
    DNA Cell Biol; 2018 Apr; 37(4):336-346. PubMed ID: 29443542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
    Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
    PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation biomarkers for the occurrence of lung adenocarcinoma from TCGA data mining.
    Zhu XF; Zhu BS; Wu FM; Hu HB
    J Cell Physiol; 2018 Oct; 233(10):6777-6784. PubMed ID: 29667778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
    Dong M; Yang Z; Li X; Zhang Z; Yin A
    Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.